98%
921
2 minutes
20
High-fat diet (HFD) and Streptococcus agalactiae are common pathogenic factors affecting tilapia health, yet their combined effects and underlying mechanisms are not well understood. To address this, we conducted a comprehensive evaluation of the potential response mechanisms in tilapia subjected to both factors. Tilapia were fed normal (NC) or high-fat diet (HFD) for 90 days, then challenged with S. agalactiae. At 48 h post-infection, blood, liver, and spleen samples were collected for biochemical parameter analysis and gene expression profiling. The results indicated that the combined treatment upregulated the expression of peroxisome proliferator-activated receptor α (pparα) and fatty acid transport protein 1 (fatp1). Concurrently, it increased 3-hydroxy-3-methylglutaryl-CoA reductase (hmgcr) expression, while decreasing cholesterol 7α-hydroxylase (cyp7a1) expression compared to HFD alone. Antioxidant status analysis revealed that the combined treatment decreased glutathione (GSH) content, total antioxidant capacity (T-AOC), and mRNA levels of nuclear factor erythroid 2-related factor 2 (nrf2), NAD(P)H quinone dehydrogenase 1 (nqo1), and glutathione peroxidase 3 (gpx3). Intriguingly, while both individual stressors upregulated inflammatory and immune-related genes, their combination suppressed interleukin-1β (il-1β), il-8, and immunoglobulin M (igm) expression compared to infection alone. The apoptotic response triggered by S. agalactiae infection, characterized by elevated caspase-3 (cas3), cas9, and cytochrome c (cytc), was inhibited in the liver of combined treatment group. Moreover, all experimental groups showed elevated expression of endoplasmic reticulum stress-related genes: inositol-requiring enzyme 1 (ire1), eukaryotic translation initiation factor 2 alpha kinase 3 (eif2ak3), activating transcription factor 6 (atf6), and binding immunoglobulin protein (bip). These findings collectively demonstrated that HFD exacerbated the pathogenic effects of S. agalactiae through multiple mechanisms, including metabolic dysregulation, oxidative stress potentiation, and complex immunomodulation. Furthermore, the Nrf2 and NF-kB signaling pathways may be implicated in mediating these adverse effects.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.cbpc.2025.110321 | DOI Listing |
Int J Biol Macromol
September 2025
Key Laboratory of Hepatosplenic Surgery, Ministry of Education, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
Life Sci
September 2025
Department of Experimental Medical Science, Faculty of Medicine, Lund University, 221 84, Lund, Sweden; Wallenberg Center for Molecular Medicine, Faculty of Medicine, Lund University, 221 84, Lund, Sweden. Electronic address:
Aims: Experimental evidence suggests an important role for sphingosine-1-phosphate (S1P) and its generating enzymes sphingosine kinase 1/2 (SphK1/2) in obesity. We and others have shown that plasma S1P levels are elevated in obese mice and humans. Preclinical studies suggest that genetic SphK2 ablation in mice protects from age- and diet-induced obesity and metabolic dysfunction.
View Article and Find Full Text PDFBiochem Pharmacol
September 2025
Guizhou Medical University, Guiyang 550004 Guizhou, PR China; Department of Cardiovascular Medicine, The Affiliated Hospital of Guizhou Medical University, Guiyang 550004 Guizhou, PR China; The Key Laboratory of Myocardial Remodeling Research, The Affiliated Hospital of Guizhou Medical University, G
Atherosclerosis (AS), a chronic inflammatory disease and a leading cause of cardiovascular morbidity and mortality. Macrophage-mediated lipid uptake and inflammation are central to plaque formation. TREM2, an immunoreceptor expressed in macrophages, has been reported to regulate lipid metabolism and inflammation, yet its role in atherosclerosis remains controversial.
View Article and Find Full Text PDFBiochem Pharmacol
September 2025
Department of Endocrinology, First Hospital of Shanxi Medical University, Shanxi Medical University, Taiyuan 030001, China. Electronic address:
Metabolic dysfunction-associated steatohepatitis (MASH) affects a large proportion of the global population and is widely regarded as the fastest growing cause of hepatocellular carcinoma. Currently, approved therapeutic strategies for MASH are limited. Therefore, this study used the Connectivity Map (CMap) database to identify a candidate compound for MASH, evaluate its efficacy in experimental models, and explore its mechanism of action.
View Article and Find Full Text PDFCell Metab
August 2025
Section of Integrative Physiology and Metabolism, Joslin Diabetes Center, Harvard Medical School, Boston, MA, USA. Electronic address:
Diet and obesity contribute to insulin resistance and type 2 diabetes, in part via the gut microbiome. To explore the role of gut-derived metabolites in this process, we assessed portal/peripheral blood metabolites in mice with different risks of obesity/diabetes, challenged with a high-fat diet (HFD) + antibiotics. In diabetes/obesity-prone C57BL/6J mice, 111 metabolites were portally enriched and 74 were peripherally enriched, many of which differed in metabolic-syndrome-resistant 129S1/129S6 mice.
View Article and Find Full Text PDF